ADCT   $4.07  5.44% Market Open

ADC Therapeutics SA
Total Cash 300.12M
totalCashPerShare 3.105
EBITDA -137.47M
Total Debt 440.61M
quickRatio 5.604
currentRatio 6.166
Total Revenue 66.75M
debtToEquity
Revenue/Share 0.779
ROA -0.19734
ROE
grossProfits
freeCashflow -99.86M
operatingCashflow -145.25M
earningsGrowth
revenueGrowth -0.097
grossMargins -0.68685997
ebitdaMargins -2.05964
operatingMargins -1.66806
profitMargins 0.0
enterpriseValue 435.26M
forwardPE -0.5063291
floatShares 77.05M
sharesOutstanding 96.69M
sharesShort 3.51M
sharesShortPriorMonth 3.14M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.21%
heldPercentInstitutions 0.59%
Short Ratio help_outline 9.05%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue -1.365
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -214.91M
trailingEps -2.54%
forwardEps -6.32%
enterpriseToEbitda -3.17
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.39 3Q 2024
institutionsCount 98
lastUpdated Nov. 7, 2024, 3:14 a.m.